13 Results for "

VSIG4

" in MedChemExpress (MCE) Product Catalog:
Products (13)

13 Results for "VSIG4" in MCE Product Catalog:

Cat. No.: HY-RS15709
Research Areas:  

Others

VSIG4 Human Pre-designed siRNA Set A contains three designed siRNAs for VSIG4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS17561
Research Areas:  

Others

Vsig4 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Vsig4 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS24019
Research Areas:  

Others

Vsig4 Rat Pre-designed siRNA Set A contains three designed siRNAs for Vsig4 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-P991181

Research Areas:  

Cancer

VTX-1218 is a VSIG4 inhibitor with human Kd 7.4 nM. VTX-1218 blocks VSIG4 activity, relieves VSIG4-mediated macrophage suppression, repolarizes tumor-associated macrophages and induces T cell activation. VTX-1218 upregulates cytokines and chemokines linked to immune cell recruitment. VTX-1218 can be used for the research of multiple cancer types .
loading...
    loading...
Cat. No.: HY-P991217

Research Areas:  

Cancer

EU-103 is a humanized monoclonal antibody targeting V-Set And Immunoglobulin Domain Containing 4 (VSIG4) with a KD value ranging from 10 −7 and 10 −9. EU-103 blocks the interaction between VSIG4 and CD8+ T cells, promotes the conversion of M2 macrophages into M1 macrophages, induces the proliferation of CD8+ T cells and the secretion of pro-inflammatory cytokines, thereby inhibiting tumor growth. EU-103 is promising for research of cancers, such as bladder cancer, breast cancer, and colon cancer .
loading...
    loading...
Cat. No.: HY-P71006
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: VSIG4; V-set and immunoglobulin domain containing 4;
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-P71423
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: V-set and immunoglobulin domain-containing protein 4; VSIG4; Protein Z39Ig; Z39IG; CRIg
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-P705243
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: V-set and immunoglobulin domain-containing protein 4; VSIG4; Protein Z39Ig; Z39IG; CRIg
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-P71424
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: V-Set and Immunoglobulin Domain-Containing Protein 4; Protein Z39Ig; VSIG4; CRIg; Z39IG
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-P700898
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: CRIg; Z39IG; VSIG4
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-P76699
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: V-set and immunoglobulin domain-containing protein 4; Protein Z39Ig; Z39IG; CRIg
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-184555
Research Areas:  

Cancer

TP-18 is a potent and orally active dual EP2/EP4 antagonist with IC50 values of 9.5 nM (EP2) and 3.3 nM (EP4). TP-18 effectively depletes a highly immunosuppressive VSIG4high tumor-associated macrophage (TAM) subset and enhances cytotoxic CD8+ T cell-mediated colorectal cancer (CRC) tumor elimination. TP-18 dampens the expression of VSIG4 by blunting EP2/EP4-Gαs-PKA signaling. TP-18 enhances the sensitivity of anti-PD-1 therapy in CRC mouse models and in patient-derived tumor immune organoids. TP-18 can be used to study colorectal cancer .
loading...
    loading...
Cat. No.: HY-P87145
Synonyms: Complement receptor of the immunoglobulin superfamily antibody; CRIg antibody; Ig superfamily protein antibody; Protein Z39Ig antibody; UNQ317/PRO362 antibody; V set and immunoglobulin domain containing 4 antibody; V-set and immunoglobulin domain-containing protein 4 antibody; VSIG4 antibody; VSIG4_HUMAN antibody; Z39IG antibody;

Host:  

Rabbit

Application:  

WB, IHC-P

Reactivity:  

Human

loading...
    loading...
  • 1